Cinitapride is indicated for the treatment of gastrointestinal disorders associated with motility disturbances such as gastroesophageal reflux disease, non-ulcer dyspepsia and delayed gastric emptying. It is a gastroprokinetic agent and antiulcer agent of the benzamide class which is marketed in India, Mexico, Pakistan and Spain.. Reference standards of Cinitapride API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below
Cinitapride
Catalogue No.:PA 30 54000
CAS :
Molecular Formula : C21H30N4O4
Molecular Weight : 402.49
Cinitapride Tartrate
Catalogue No.:PA 30 54510
Molecular Formula : C25H36N4O10
Molecular Weight : 552.57
4-Amino-2-ethoxy-5-nitro-N-4-piperidinyl-benzamide Hydrobromide
Catalogue No.:PA 30 54520
Molecular Formula : C14H21BrN4O4
Molecular Weight : 389.24
4-[(4-Amino-2-ethoxy-5-nitrobenzoyl)amino]-1-piperidinecarboxylic Acid Ethyl Ester
Catalogue No.:PA 30 54530
Molecular Formula : C17H24N4O6
Molecular Weight : 380.4
4-Amino-2-ethoxy-5-nitrobenzoic Acid
Catalogue No.:PA 30 54540
Molecular Formula : C9H10N2O5
Molecular Weight : 226.19
4-Amino-2-ethoxy-5-nitrobenzoic Acid Methyl Ester
Catalogue No.:PA 30 54550
Molecular Formula : C10H12N2O5
Molecular Weight : 240.21
4-Amino-2-hydroxy-5-nitro-N-4-piperidinyl-benzamide Hybromide
Catalogue No.:PA 30 54560
Molecular Formula : C12H17BrN4O4
Molecular Weight : 361.19
3-Cyclohexene-1-methanol Methanesulfonate
Catalogue No.:PA 30 0541000
Molecular Formula : C8H14O3S
Molecular Weight : 190.26
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
